Journal of Emergency Nursing
Volume 35, Issue 4 , Pages 348-349 , July 2009

A 44-year-old Man With Neurocysticercosis

  • Sherry Remy, MSN, RN, CEN

      Affiliations

    • Corresponding Author InformationFor correspondence, write: Sherry Remy, MSN, RN, CEN, South Jersey Healthcare, 1505 W Sherman Ave, Vineland, NJ 08360

References 

  1. Hutcheson K, Kalafian M, Taylor I, Sagel J, Clyburn B. Neurocysticercosis. South Med J. 2000;7:666–668
  2. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician. 2007;76:91–96
  3. Mehta SS, Hatfield S, Jessen L, Vogel D. Albendazole versus praziquantel for neurocysticercosis. Am J Health Syst Pharm. 1998;55:598–600
  4. Gongora-Rivera F, Soto-Hernandez JL, Gonzalez Esquivel D, Cook HJ, Marquez-Caraveo C, Hernandez Davila R, et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology. 2006;66:436–438

 Section Editor: Laura M. Criddle, PhD, RN, CEN, CFRN, FAEN

 Earn Up to 8 CE Hours. See page 394.

 This section features actual emergency situations with particular educational value for the emergency nurse. Contributions (3 to 5 typed, double-spaced pages) should include a case summary focused on the emergency care phase, accompanied by pertinent case commentary.Submissions to this column are encouraged and may be sent toLaura M. Criddle, PhD, RN, CEN, CFRN, FAENhttp://ees.elsevier.com/jen/

PII: S0099-1767(08)00214-6

doi: 10.1016/j.jen.2008.04.024

Journal of Emergency Nursing
Volume 35, Issue 4 , Pages 348-349 , July 2009

Article Tools